Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2025-12-25 @ 1:12 AM
NCT ID:
NCT05618093
Eligibility Criteria:
Inclusion Criteria:
* Patient ≥ 18 years of age.
* The patient must understand and sign informed consent form (ICF).
* Patients with a confirmed diagnosis or suspected diagnosis of pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) prior to initiation or change in therapy.
* PAH or CTEPH patients undergoing right heart catheterization (RHC) as part of their standard of care.
Exclusion Criteria:
* BMI \< 20 or BMI \> 35.
* Height less than 120 cm.
* Diagnosis of atrial fibrillation, aortic or mitral valve insufficiency or stenosis, or end-stage renal disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05618093
Study Brief:
Protocol Section:
NCT05618093